Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998. |
|||||||||||||||||||||
Editas Medicine (NQ: EDIT )Price and VolumeDetailed Quote
Top NewsMore NewsPerformanceMore NewsRead More
The Latest Analyst Ratings For Editas Medicine
February 29, 2024
Earnings Outlook For Editas Medicine
February 27, 2024
Editas Medicine to Participate in Upcoming Investor Conferences
January 31, 2024
2 Under-the-Radar Stocks With Incredible Upside Potential
January 28, 2024
Could Editas Medicine Become the Next CRISPR Therapeutics?
January 21, 2024
7 Mighty Healthcare Stocks Changing the Game of Medicine
January 17, 2024
Down 88%, Could Editas Medicine Be a Good Investment Now?
January 15, 2024
3 Stocks to Buy in the Booming Field of Gene Editing
January 11, 2024
Better Gene-Editing Stock: Editas Medicine vs. Intellia Therapeutics
January 08, 2024
2 gene-editing stocks reshaping hereditary disease treatments
January 02, 2024
Editas Just Caught a Break Thanks to Vertex Pharmaceuticals
December 23, 2023
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|
||||||||||||||||||||
|